Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
Tags:
Funding Contract Politics

Two strengths of prednisolone among final September price concessions

  • News

The Department of Health and Social Care and the National Assembly for Wales have agreed on concessionary prices for the following 17 items for September 2020 prescriptions.

  • Eliza Slawther
Drug
Strength
Form
Price
Duloxetine
40mg
gastro-resistant capsules (56)
£13.30
Entacapone
200mg
tablets (30)
£12.99
Irbesartan with hydrochlorothiazide
300/12.5mg
tablets (28)
£14.31
Moxonidine
200 microgram
tablets (28)
£6.12
Moxonidine
300 microgram
tablets (28)
£8.69
Moxonidine
400 microgram
tablets (28)
£8.50
Nizatidine
150mg
capsules (30)
£7.01
Olanzapine
10mg
tablets (28)
£2.66
Olanzapine
2.5mg
tablets (28)
£1.51
Olanzapine
15mg
tablets (28)
£3.84
Oxytetracycline
250mg
tablets (28)
£8.85
Prednisolone
10mg
tablets (30)
£15.26
Prednisolone
2.5mg
tablets (30)
£3.80
Tamoxifen
20mg
tablets (30)
£14.69
Valaciclovir
500mg
tablets (10)
£19.68
Valproic acid
300mg
gastro-resistant capsules (100)
£22.77
Zonisamide
100mg
capsules (56)
£62.72
Table

View full table

Do these prices reflect what you paid in September?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Tags:
Funding Contract Politics
Latest News & Analysis

GPhC to 'assess' pharmacy technician minimum training levels

£5m retained margin uplift ‘approved’ in Northern Ireland

Revealed: London pharmacies will offer children’s MMR jabs following case surge

Will expanding access to naloxone OTC be the right move?

See All
UsernamePublicRestriction

Register

CD006759

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By